PhRMA Alters Their Code on Interactions: How to Prepare
PhRMA has adjusted its Code on Interactions, partly in response to the Special Fraud Alert issued by the OIG. Pro-ficiency is on a mission is to eliminate protocol deviations, one […]
As Head of Regulatory Affairs and general council at Pro-ficiency, Margaret is committed to improving the clinical trial experience and bringing new solutions to market safely and ethically. With over 25 years of experience in the regulatory and legal fields of the life sciences, she has taken on the challenge of managing several trials across the globe throughout her impressive career. She brings this same dedication in developing new ideas and progressing clinical innovation at Pro-ficiency.